Commons Sense

House of Commons · Written Ministerial Statement

Covid-19 Update

23 February 2022 · Department of Health and Social Care

Proposed by Maggie Throup Con Erewash

NHS

Summarised by AI from the official record, so it can contain mistakes.

View on Parliament.uk

At a glance

Key points

  • The UK's COVID-19 vaccination programme is updated to include advice for children aged 5 to 11 from the JCVI.
  • The NHS will implement a non-urgent vaccine offer for children aged 5 to 11 in due course.
  • A spring booster dose is recommended for eligible individuals six months after their last vaccine dose.

Issue summary

The statement updates on the UK's ongoing COVID-19 vaccination programme, including advice from the JCVI for children aged 5 to 11 and a spring booster dose offer.

Action requested

The NHS will operationalise the non-urgent vaccine offer for children aged 5 to 11 in due course. A spring booster dose is advised for eligible individuals six months after their last vaccine dose, with deployment expected based on JCVI's definitive advice nearer the time.

Key facts

  • Over 139 million doses have been provided as of February 19, 2022.
  • 52.5 million first doses, 48.8 million second doses, and 37.9 million third primary and booster doses were administered in the UK.
  • Uptake is at 91.4% for the first dose, 85% for the second dose, and 66.1% for the third primary and booster doses.
  • JCVI advises a non-urgent offer of two 10 micrograms Pfizer vaccine doses to children aged 5 to 11 years old with an interval of at least 12 weeks between doses.
  • A spring booster dose is recommended around six months after the last vaccine dose for eligible individuals aged 18 and over, and 12 to less than 18 years.
▸ Assessment & feedback
Summary accuracy